Naiquan Mao
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Journal: The New England journal of medicine
Published: July 08, 2026
Connexin43 Promotes the Invasion and Metastasis of Lung Squamous Cell Carcinoma via GJIC-Dependent Ca2+/ERK Signaling Activation.
Journal: Cancer science
Published: November 15, 2024
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial.
Journal: The Lancet. Respiratory medicine
Published: April 04, 2024
Endothoracic lymphatic plexus‑hemiazygos vein anastomosis for chylothorax complicated with hepatocellular carcinoma: A case report.
Journal: Experimental and therapeutic medicine
Published: May 08, 2023
CEMIP-mediated hyaluronan metabolism facilitates SCLC metastasis by activating TLR2/c-Src/ERK1/2 axis.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: August 22, 2022
Expression and Predictive Significance of FHL1 and SLIT3 in Surgically Resected Lung Adenocarcinoma.
Expression and Predictive Significance of FHL1 and SLIT3 in Surgically Resected Lung Adenocarcinoma.
Journal: Combinatorial chemistry & high throughput screening
Published: May 24, 2022
External validation of the eighth edition of the TNM classification for lung cancer in small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 23, 2022
Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou).
Journal: Translational lung cancer research
Published: June 18, 2021
Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Journal: Journal of cancer research and clinical oncology
Published: September 15, 2020
A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis.
Journal: Journal of cancer research and clinical oncology
Published: April 03, 2020
NFE2L2/KEAP1 Mutations Correlate with Higher Tumor Mutational Burden Value/PD-L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy.
Journal: The oncologist
Published: November 19, 2019
Diagnosis of NUT carcinoma of lung origin by next-generation sequencing: case report and review of the literature.
Journal: Cancer biology & therapy
Published: October 12, 2018
Last Updated: 09/26/2026